Computational Design of Phosphatidylinositol 3-Kinase Inhibitors

Isha Rani1,2, Anju Goyal1, M Sharma3

  • 1Chitkara College of Pharmacy, Chitkara University, Punjab, India.

Insights

Researchers designed novel pyrimidine derivatives as potential anticancer agents targeting phosphoinositide 3-kinase (PI3K). Compounds IV and XIV demonstrated potent PI3K inhibition and stability, showing promise for future cancer therapies.

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Oncology

Background:

  • The phosphoinositide 3-kinase (PI3K) pathway is crucial in cell signaling and frequently dysregulated in human cancers.
  • Existing anticancer therapies face challenges including drug resistance and dose-limiting adverse effects.

Purpose of the Study:

  • To design and evaluate novel pyrimidine derivatives as potential inhibitors of human PI3K.
  • To identify potent PI3K inhibitors with favorable binding stability for anticancer drug development.

Main Methods:

  • Molecular docking analysis was employed to screen pyrimidine derivatives against the human PI3K receptor.
  • Molecular dynamic simulations were conducted to assess the stability and binding interactions of promising compounds.

Main Results:

  • Compounds IV and XIV emerged as the most potent inhibitors of human PI3K.
  • These compounds exhibited high stability within the PI3K active site over a 50 ns simulation period.

Conclusions:

  • Compounds IV and XIV represent promising drug candidates for developing novel PI3K inhibitors.
  • These findings support the potential of these pyrimidine derivatives as prospective anticancer agents targeting the PI3K pathway.

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.7K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.3K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K